-
Something wrong with this record ?
Chronic endothelin A receptor blockade attenuates contribution of sympathetic nervous system to salt hypertension development in adult but not in young Dahl rats
J. Zicha, Z. Dobešová, J. Kuneš, I. Vaněčková,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Medline Complete (EBSCOhost)
from 2006-01-01 to 1 year ago
Wiley Online Library (archiv)
from 1889-01-01 to 2012-12-31
- MeSH
- Endothelin A Receptor Antagonists MeSH
- Diet, Sodium-Restricted MeSH
- Phenylpropionates pharmacology MeSH
- Hypertension chemically induced physiopathology MeSH
- Blood Pressure drug effects physiology MeSH
- Rats MeSH
- Sodium Chloride, Dietary pharmacology MeSH
- Rats, Inbred Dahl MeSH
- Pyridazines pharmacology MeSH
- Receptor, Endothelin A MeSH
- Sympathetic Nervous System drug effects physiopathology MeSH
- Age Factors MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
AIM: Endothelin-1 (ET-1) plays an important role in the pathogenesis of salt-dependent forms of hypertension in adult rats, but its participation in salt hypertension elicited in immature rats is still unknown. Therefore, we compared ET-1 role in the development or the maintenance of salt hypertension induced in young (4-week-old) or adult (12-week-old) Dahl rats. METHODS: The contribution of pressor ET-1 effects to the maintenance of high blood pressure (BP) was studied using acute injection of ET(A) receptor antagonist ambrisentan (BSF 208075, 1 mg kg(-1) iv) to young or adult rats with established salt hypertension. Furthermore, using chronic ambrisentan treatment (30 mg kg(-1) day(-1) in the drinking fluid during 5 weeks of high salt intake), we investigated the age-dependent involvement of ET(A) receptors in salt hypertension development in these two age groups. RESULTS: Acute ET(A) receptor blockade lowered BP in both age groups of salt hypertensive Dahl rats more than in rats fed a low-salt diet (but without any age-dependent difference). Chronic ET(A) receptor blockade strongly attenuated the development of salt hypertension and cardiac hypertrophy in adult rats, but it had no significant effects on salt hypertension in young animals. Pronounced BP reduction induced in adult salt hypertensive rats by chronic ambrisentan treatment was attributed to attenuated sympathetic BP component, without changes in nitric oxide (NO)-dependent BP regulation. In contrast, chronic ambrisentan treatment of young animals did not modify sympathetic BP component but substantially attenuated NO-dependent vasodilatation. CONCLUSIONS: ET(A) receptor-mediated ET-1 effects play an important role in salt hypertension of adult but not young Dahl rats.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12034617
- 003
- CZ-PrNML
- 005
- 20121206103901.0
- 007
- ta
- 008
- 121023s2012 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/j.1748-1716.2012.02395.x $2 doi
- 035 __
- $a (PubMed)22463612
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Zicha, J $u Center for Experimental Cardiovascular Research, Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. zicha@biomed.cas.cz
- 245 10
- $a Chronic endothelin A receptor blockade attenuates contribution of sympathetic nervous system to salt hypertension development in adult but not in young Dahl rats / $c J. Zicha, Z. Dobešová, J. Kuneš, I. Vaněčková,
- 520 9_
- $a AIM: Endothelin-1 (ET-1) plays an important role in the pathogenesis of salt-dependent forms of hypertension in adult rats, but its participation in salt hypertension elicited in immature rats is still unknown. Therefore, we compared ET-1 role in the development or the maintenance of salt hypertension induced in young (4-week-old) or adult (12-week-old) Dahl rats. METHODS: The contribution of pressor ET-1 effects to the maintenance of high blood pressure (BP) was studied using acute injection of ET(A) receptor antagonist ambrisentan (BSF 208075, 1 mg kg(-1) iv) to young or adult rats with established salt hypertension. Furthermore, using chronic ambrisentan treatment (30 mg kg(-1) day(-1) in the drinking fluid during 5 weeks of high salt intake), we investigated the age-dependent involvement of ET(A) receptors in salt hypertension development in these two age groups. RESULTS: Acute ET(A) receptor blockade lowered BP in both age groups of salt hypertensive Dahl rats more than in rats fed a low-salt diet (but without any age-dependent difference). Chronic ET(A) receptor blockade strongly attenuated the development of salt hypertension and cardiac hypertrophy in adult rats, but it had no significant effects on salt hypertension in young animals. Pronounced BP reduction induced in adult salt hypertensive rats by chronic ambrisentan treatment was attributed to attenuated sympathetic BP component, without changes in nitric oxide (NO)-dependent BP regulation. In contrast, chronic ambrisentan treatment of young animals did not modify sympathetic BP component but substantially attenuated NO-dependent vasodilatation. CONCLUSIONS: ET(A) receptor-mediated ET-1 effects play an important role in salt hypertension of adult but not young Dahl rats.
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krevní tlak $x účinky léků $x fyziologie $7 D001794
- 650 _2
- $a dieta s nízkým obsahem soli $7 D004039
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hypertenze $x chemicky indukované $x patofyziologie $7 D006973
- 650 _2
- $a fenylpropionáty $x farmakologie $7 D010666
- 650 _2
- $a pyridaziny $x farmakologie $7 D011724
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani inbrední Dahl $7 D020303
- 650 _2
- $a receptor endotelinu A $7 D044022
- 650 _2
- $a kuchyňská sůl $x farmakologie $7 D017673
- 650 _2
- $a sympatický nervový systém $x účinky léků $x patofyziologie $7 D013564
- 650 _2
- $a antagonisté endotelinového receptoru A $7 D065130
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dobešová, Z
- 700 1_
- $a Kuneš, J
- 700 1_
- $a Vaněčková, I
- 773 0_
- $w MED00154561 $t Acta physiologica (Oxford, England) $x 1748-1716 $g Roč. 205, č. 1 (2012), s. 124-32
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22463612 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a
- 990 __
- $a 20121023 $b ABA008
- 991 __
- $a 20121206103934 $b ABA008
- 999 __
- $a ok $b bmc $g 956627 $s 792114
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 205 $c 1 $d 124-32 $i 1748-1716 $m Acta physiologica $n Acta Physiol $x MED00154561
- LZP __
- $a Pubmed-20121023